<DOC>
	<DOCNO>NCT02114346</DOCNO>
	<brief_summary>The aim study determine efficacy atorvastatin prevention contrast-induced nephropathy patient undergo computed tomography coronary angiography . Investigators assume atorvastatin effective regard . Investigators include patient refer elective compute tomography coronary angiography allocate atorvastatin placebo 24 hour 48 hour administration contrast material . Investigators measure serum creatinine see raise ≥ 0.5 mg/dL ≥ 25 % baseline value .</brief_summary>
	<brief_title>High Dose Atorvastatin Preventing Contrast-induced Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>adult patient candidate elective compute tomography angiogram willingness participate unstable angina myocardial infarction , cardiac arrhythmia , seizure , acute renal failure , endstage renal disease unstable serum creatinine unstable hemodynamic intravascular administration contrast material past month use high dose atorvastatin past month , know hypersensitivity atorvastatin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Computed Tomography Angiogram</keyword>
	<keyword>Side Effects</keyword>
	<keyword>Contrast-Induced Nephropathy</keyword>
	<keyword>Prevention</keyword>
</DOC>